Global Sickle Cell Anemia Therapeutics Market Insights and Forecast to 2028

Report ID: 1542695 | Published Date: Jan 2025 | No. of Page: 117 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Blood Transfusion
        1.2.3 Pharmacotherapy
        1.2.4 Bone Marrow Transplant
    1.3 Market by Application
        1.3.1 Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Child
        1.3.3 Adult
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Sickle Cell Anemia Therapeutics Market Perspective (2017-2028)
    2.2 Sickle Cell Anemia Therapeutics Growth Trends by Region
        2.2.1 Sickle Cell Anemia Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Sickle Cell Anemia Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Sickle Cell Anemia Therapeutics Market Dynamics
        2.3.1 Sickle Cell Anemia Therapeutics Industry Trends
        2.3.2 Sickle Cell Anemia Therapeutics Market Drivers
        2.3.3 Sickle Cell Anemia Therapeutics Market Challenges
        2.3.4 Sickle Cell Anemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Sickle Cell Anemia Therapeutics Players by Revenue
        3.1.1 Global Top Sickle Cell Anemia Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Sickle Cell Anemia Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Sickle Cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Sickle Cell Anemia Therapeutics Revenue
    3.4 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio
        3.4.1 Global Sickle Cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Anemia Therapeutics Revenue in 2021
    3.5 Sickle Cell Anemia Therapeutics Key Players Head office and Area Served
    3.6 Key Players Sickle Cell Anemia Therapeutics Product Solution and Service
    3.7 Date of Enter into Sickle Cell Anemia Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Anemia Therapeutics Breakdown Data by Type
    4.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (2023-2028)
5 Sickle Cell Anemia Therapeutics Breakdown Data by Application
    5.1 Global Sickle Cell Anemia Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Sickle Cell Anemia Therapeutics Market Size (2017-2028)
    6.2 North America Sickle Cell Anemia Therapeutics Market Size by Type
        6.2.1 North America Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Sickle Cell Anemia Therapeutics Market Share by Type (2017-2028)
    6.3 North America Sickle Cell Anemia Therapeutics Market Size by Application
        6.3.1 North America Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Sickle Cell Anemia Therapeutics Market Share by Application (2017-2028)
    6.4 North America Sickle Cell Anemia Therapeutics Market Size by Country
        6.4.1 North America Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Sickle Cell Anemia Therapeutics Market Size (2017-2028)
    7.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type
        7.2.1 Europe Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Sickle Cell Anemia Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Sickle Cell Anemia Therapeutics Market Size by Application
        7.3.1 Europe Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Sickle Cell Anemia Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Sickle Cell Anemia Therapeutics Market Size by Country
        7.4.1 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Sickle Cell Anemia Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Sickle Cell Anemia Therapeutics Market Size (2017-2028)
    9.2 Latin America Sickle Cell Anemia Therapeutics Market Size by Type
        9.2.1 Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Sickle Cell Anemia Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Sickle Cell Anemia Therapeutics Market Size by Application
        9.3.1 Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Sickle Cell Anemia Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Sickle Cell Anemia Therapeutics Market Size by Country
        9.4.1 Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Sickle Cell Anemia Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Emmaus Medical
        11.1.1 Emmaus Medical Company Details
        11.1.2 Emmaus Medical Business Overview
        11.1.3 Emmaus Medical Sickle Cell Anemia Therapeutics Introduction
        11.1.4 Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.1.5 Emmaus Medical Recent Developments
    11.2 Addmedica
        11.2.1 Addmedica Company Details
        11.2.2 Addmedica Business Overview
        11.2.3 Addmedica Sickle Cell Anemia Therapeutics Introduction
        11.2.4 Addmedica Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.2.5 Addmedica Recent Developments
    11.3 Gamida Cell
        11.3.1 Gamida Cell Company Details
        11.3.2 Gamida Cell Business Overview
        11.3.3 Gamida Cell Sickle Cell Anemia Therapeutics Introduction
        11.3.4 Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.3.5 Gamida Cell Recent Developments
    11.4 GlycoMimetics
        11.4.1 GlycoMimetics Company Details
        11.4.2 GlycoMimetics Business Overview
        11.4.3 GlycoMimetics Sickle Cell Anemia Therapeutics Introduction
        11.4.4 GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.4.5 GlycoMimetics Recent Developments
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Sickle Cell Anemia Therapeutics Introduction
        11.5.4 Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.5.5 Pfizer Recent Developments
    11.6 Novartis
        11.6.1 Novartis Company Details
        11.6.2 Novartis Business Overview
        11.6.3 Novartis Sickle Cell Anemia Therapeutics Introduction
        11.6.4 Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.6.5 Novartis Recent Developments
    11.7 Global Blood Therapeutics
        11.7.1 Global Blood Therapeutics Company Details
        11.7.2 Global Blood Therapeutics Business Overview
        11.7.3 Global Blood Therapeutics Sickle Cell Anemia Therapeutics Introduction
        11.7.4 Global Blood Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.7.5 Global Blood Therapeutics Recent Developments
    11.8 Micelle BioPharma
        11.8.1 Micelle BioPharma Company Details
        11.8.2 Micelle BioPharma Business Overview
        11.8.3 Micelle BioPharma Sickle Cell Anemia Therapeutics Introduction
        11.8.4 Micelle BioPharma Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.8.5 Micelle BioPharma Recent Developments
    11.9 Bluebird Bio
        11.9.1 Bluebird Bio Company Details
        11.9.2 Bluebird Bio Business Overview
        11.9.3 Bluebird Bio Sickle Cell Anemia Therapeutics Introduction
        11.9.4 Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.9.5 Bluebird Bio Recent Developments
    11.10 Prolong Pharmaceuticals
        11.10.1 Prolong Pharmaceuticals Company Details
        11.10.2 Prolong Pharmaceuticals Business Overview
        11.10.3 Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction
        11.10.4 Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.10.5 Prolong Pharmaceuticals Recent Developments
    11.11 Modus Therapeutics
        11.11.1 Modus Therapeutics Company Details
        11.11.2 Modus Therapeutics Business Overview
        11.11.3 Modus Therapeutics Sickle Cell Anemia Therapeutics Introduction
        11.11.4 Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.11.5 Modus Therapeutics Recent Developments
    11.12 Sangamo Biosciences
        11.12.1 Sangamo Biosciences Company Details
        11.12.2 Sangamo Biosciences Business Overview
        11.12.3 Sangamo Biosciences Sickle Cell Anemia Therapeutics Introduction
        11.12.4 Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.12.5 Sangamo Biosciences Recent Developments
    11.13 Bioverativ
        11.13.1 Bioverativ Company Details
        11.13.2 Bioverativ Business Overview
        11.13.3 Bioverativ Sickle Cell Anemia Therapeutics Introduction
        11.13.4 Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.13.5 Bioverativ Recent Developments
    11.14 Imara
        11.14.1 Imara Company Details
        11.14.2 Imara Business Overview
        11.14.3 Imara Sickle Cell Anemia Therapeutics Introduction
        11.14.4 Imara Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.14.5 Imara Recent Developments
    11.15 Ironwood Pharmaceuticals
        11.15.1 Ironwood Pharmaceuticals Company Details
        11.15.2 Ironwood Pharmaceuticals Business Overview
        11.15.3 Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Introduction
        11.15.4 Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022)
        11.15.5 Ironwood Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Blood Transfusion
    Table 3. Key Players of Pharmacotherapy
    Table 4. Key Players of Bone Marrow Transplant
    Table 5. Global Sickle Cell Anemia Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Sickle Cell Anemia Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Sickle Cell Anemia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Sickle Cell Anemia Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Sickle Cell Anemia Therapeutics Market Share by Region (2023-2028)
    Table 11. Sickle Cell Anemia Therapeutics Market Trends
    Table 12. Sickle Cell Anemia Therapeutics Market Drivers
    Table 13. Sickle Cell Anemia Therapeutics Market Challenges
    Table 14. Sickle Cell Anemia Therapeutics Market Restraints
    Table 15. Global Sickle Cell Anemia Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Sickle Cell Anemia Therapeutics Revenue Share by Players (2017-2022)
    Table 17. Global Top Sickle Cell Anemia Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Therapeutics as of 2021)
    Table 18. Ranking of Global Top Sickle Cell Anemia Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Sickle Cell Anemia Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Sickle Cell Anemia Therapeutics Product Solution and Service
    Table 22. Date of Enter into Sickle Cell Anemia Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Sickle Cell Anemia Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Sickle Cell Anemia Therapeutics Revenue Share by Application (2017-2022)
    Table 30. Global Sickle Cell Anemia Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Sickle Cell Anemia Therapeutics Revenue Share by Application (2023-2028)
    Table 32. North America Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Sickle Cell Anemia Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Emmaus Medical Company Details
    Table 63. Emmaus Medical Business Overview
    Table 64. Emmaus Medical Sickle Cell Anemia Therapeutics Product
    Table 65. Emmaus Medical Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Emmaus Medical Recent Developments
    Table 67. Addmedica Company Details
    Table 68. Addmedica Business Overview
    Table 69. Addmedica Sickle Cell Anemia Therapeutics Product
    Table 70. Addmedica Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Addmedica Recent Developments
    Table 72. Gamida Cell Company Details
    Table 73. Gamida Cell Business Overview
    Table 74. Gamida Cell Sickle Cell Anemia Therapeutics Product
    Table 75. Gamida Cell Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Gamida Cell Recent Developments
    Table 77. GlycoMimetics Company Details
    Table 78. GlycoMimetics Business Overview
    Table 79. GlycoMimetics Sickle Cell Anemia Therapeutics Product
    Table 80. GlycoMimetics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. GlycoMimetics Recent Developments
    Table 82. Pfizer Company Details
    Table 83. Pfizer Business Overview
    Table 84. Pfizer Sickle Cell Anemia Therapeutics Product
    Table 85. Pfizer Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Pfizer Recent Developments
    Table 87. Novartis Company Details
    Table 88. Novartis Business Overview
    Table 89. Novartis Sickle Cell Anemia Therapeutics Product
    Table 90. Novartis Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. Novartis Recent Developments
    Table 92. Global Blood Therapeutics Company Details
    Table 93. Global Blood Therapeutics Business Overview
    Table 94. Global Blood Therapeutics Sickle Cell Anemia Therapeutics Product
    Table 95. Global Blood Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 96. Global Blood Therapeutics Recent Developments
    Table 97. Micelle BioPharma Company Details
    Table 98. Micelle BioPharma Business Overview
    Table 99. Micelle BioPharma Sickle Cell Anemia Therapeutics Product
    Table 100. Micelle BioPharma Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 101. Micelle BioPharma Recent Developments
    Table 102. Bluebird Bio Company Details
    Table 103. Bluebird Bio Business Overview
    Table 104. Bluebird Bio Sickle Cell Anemia Therapeutics Product
    Table 105. Bluebird Bio Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 106. Bluebird Bio Recent Developments
    Table 107. Prolong Pharmaceuticals Company Details
    Table 108. Prolong Pharmaceuticals Business Overview
    Table 109. Prolong Pharmaceuticals Sickle Cell Anemia Therapeutics Product
    Table 110. Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 111. Prolong Pharmaceuticals Recent Developments
    Table 112. Modus Therapeutics Company Details
    Table 113. Modus Therapeutics Business Overview
    Table 114. Modus Therapeutics Sickle Cell Anemia Therapeutics Product
    Table 115. Modus Therapeutics Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 116. Modus Therapeutics Recent Developments
    Table 117. Sangamo Biosciences Company Details
    Table 118. Sangamo Biosciences Business Overview
    Table 119. Sangamo Biosciences Sickle Cell Anemia Therapeutics Product
    Table 120. Sangamo Biosciences Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 121. Sangamo Biosciences Recent Developments
    Table 122. Bioverativ Company Details
    Table 123. Bioverativ Business Overview
    Table 124. Bioverativ Sickle Cell Anemia Therapeutics Product
    Table 125. Bioverativ Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 126. Bioverativ Recent Developments
    Table 127. Imara Company Details
    Table 128. Imara Business Overview
    Table 129. Imara Sickle Cell Anemia Therapeutics Product
    Table 130. Imara Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 131. Imara Recent Developments
    Table 132. Ironwood Pharmaceuticals Company Details
    Table 133. Ironwood Pharmaceuticals Business Overview
    Table 134. Ironwood Pharmaceuticals Sickle Cell Anemia Therapeutics Product
    Table 135. Ironwood Pharmaceuticals Revenue in Sickle Cell Anemia Therapeutics Business (2017-2022) & (US$ Million)
    Table 136. Ironwood Pharmaceuticals Recent Developments
    Table 137. Research Programs/Design for This Report
    Table 138. Key Data Information from Secondary Sources
    Table 139. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sickle Cell Anemia Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Blood Transfusion Features
    Figure 3. Pharmacotherapy Features
    Figure 4. Bone Marrow Transplant Features
    Figure 5. Global Sickle Cell Anemia Therapeutics Market Share by Application: 2021 VS 2028
    Figure 6. Child Case Studies
    Figure 7. Adult Case Studies
    Figure 8. Sickle Cell Anemia Therapeutics Report Years Considered
    Figure 9. Global Sickle Cell Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Sickle Cell Anemia Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Sickle Cell Anemia Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Sickle Cell Anemia Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Sickle Cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell Anemia Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Sickle Cell Anemia Therapeutics Revenue in 2021
    Figure 15. North America Sickle Cell Anemia Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 17. North America Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 18. North America Sickle Cell Anemia Therapeutics Market Size Share by Country (2017-2028)
    Figure 19. United States Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Sickle Cell Anemia Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Sickle Cell Anemia Therapeutics Market Size Share by Country (2017-2028)
    Figure 25. Germany Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Sickle Cell Anemia Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Sickle Cell Anemia Therapeutics Market Size Share by Region (2017-2028)
    Figure 35. China Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Sickle Cell Anemia Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Sickle Cell Anemia Therapeutics Market Size Share by Country (2017-2028)
    Figure 45. Mexico Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Sickle Cell Anemia Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Sickle Cell Anemia Therapeutics Market Size Share by Country (2017-2028)
    Figure 51. Turkey Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Sickle Cell Anemia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Emmaus Medical Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 55. Addmedica Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 56. Gamida Cell Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 57. GlycoMimetics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 58. Pfizer Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 60. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 61. Micelle BioPharma Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 62. Bluebird Bio Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 63. Prolong Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 64. Modus Therapeutics Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 65. Sangamo Biosciences Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 66. Bioverativ Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 67. Imara Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 68. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle Cell Anemia Therapeutics Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Emmaus Medical
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals
Frequently Asked Questions
Sickle Cell Anemia Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sickle Cell Anemia Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sickle Cell Anemia Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Smart Mattress

Smart Mattress market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More

Smart Water Meters

Smart Water Meters market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Sodium Percarbonate

Sodium Percarbonate market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More